Results - Announcements
Unichem Laboratories Ltd share price ticked higher by 0.04% to Rs 504.35 after the company's net profit tumbled by 46.42% to Rs 22.22 crore, while revenue from operations slightly gained 1.20% to Rs 640.22 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.73 lakh crore, gaining 4.49%. It has improved by 1.84% over last one week and ticked higher by 1.37% in last one month while the market capitalization of Unichem Laboratories Ltd has inched up 3.66% and 1.61% in the same period respectively.
Profit before tax (PBT) of Unichem Laboratories Ltd stood at Rs 27.37 crore in Q3 FY26, crashing by 352.96% year-on-year, and tanking 44.13% quarter-on-quarter. EBITDA came in at Rs 59 crore, expanding by 30.70% YoY and rising 8.76% sequentially.
Total expenses posted a minor rise of 0.61% to Rs 596.25 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 255.11 crore, soaring by 34.25% YoY, while employee benefits expense was at Rs 105.57 crore, ticking higher by 2.19% YoY.
For the TTM ended FY26, revenue from operations inched higher 4.31% to Rs 2201.85 crore, while net profit jumped 83.86% to Rs 252.84 crore, compared to previous TTM. EBITDA jumped by 22910% to Rs 121.11 crore, and PBT soared 89.13% to Rs 292.38 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 3.64 crore in FY26, as against Rs 7.02 crore in FY25.
Unichem Laboratories Ltd rose by 6.30% in last one year, significantly outperforming the benchmark BSE Sensex which has eased by 8.41% during the same period.
